FGF9 and metabolic dysfunction-associated steatohepatitis: Among 164 genes specific for NASH-fib (Fig. 2e, Supplementary Table S1), we focused on fibroblast growth factor 9 (FGF9), which was the most upregulated gene in the ‘pathways in cancer’.